Innovent Biologics
-
A 70-year relay to end the dilemma of no quality treatment for thyroid eye disease patients in China
This is an inspiring story of drug development for patients in great need
-
Exchanging a CAR-T therapy for 18% of the shares, the decision-making of Innovent Biologics
All comments are highly welcome!
-
What is the Current Landscape of Obesity Drug Development in China?
These presentations indicate that the era of domestically developed GLP-1 drugs for weight loss in China is on the horizon, with significant implications for the future of obesity treatment
